HomeNewsOpinionMoneycontrol Pro Panorama | A thawing of the MNC chill 

Moneycontrol Pro Panorama | A thawing of the MNC chill 

In today's edition of Moneycontrol Pro Panorama: Fed's higher for longer narrative backfires, headwinds eating into cement firms' profit, Aluminium output picks up, IMEEC a breakthrough for trade globalisation, and more

September 25, 2023 / 14:42 IST
Story continues below Advertisement
MNC work force
A younger management is taking over at many of the MNC subsidiaries, not just at the operational level but even board-level changes are taking place.

Dear Reader,

The Panorama newsletter is sent to Moneycontrol Pro subscribers on market days. It offers easy access to stories published on Moneycontrol Pro and gives a little extra by setting out a context or an event or trend that investors should keep track of. 
Change sometimes creeps up unnoticed. Sometimes it smacks you in the face. That’s the feeling retail investors of a certain vintage—and why even institutional investors—may have had when they saw P&G’s investor invite for an analyst meet on Friday, September 22, followed by its presentation being uploaded on the same day and even the transcript available by evening. Sure, the presentation being uploaded was a Sebi requirement but even now companies upload the transcript with a lag of several days.

Story continues below Advertisement

Talking to investors itself is not a regulatory requirement but a matter of choice, one could say. Releasing results is mandatory and most companies issue a press release at the bare minimum, but beyond that it's at their discretion what they disclose. The only condition is whatever they disclose must be known to all investors.

P&G’s listed companies in India are Procter & Gamble Hygiene & Healthcare, which sells Whisper sanitary pads and Vicks cold and cough products, and Gillette India, which sells Gillette shaving products. They were part of a group of foreign-owned companies –typically in the consumer products sector but also others such as pharmaceuticals and a few other sectors—that did not speak much to the financial community, at least openly. Their press releases would contain the barest of details, with the numbers in the results table being written in words, and the industry context and strategy would be a copy-paste of earlier releases. Very little value-added information would be given. For investors, these served very little purpose by way of explaining the quarter’s performance.